Guo C - Search Results

1

Engagement of an optimized lentiviral vector enhances the expression and cytotoxicity of CAR in human NK cells.

Guo C, Chen H, Yu J, Lu H, Xia Q, Li X, Guo X, Wang T, Zhi L, Niu Z, Zhu W. Guo C, et al. Among authors: guo x. Mol Immunol. 2023 Mar;155:91-99. doi: 10.1016/j.molimm.2023.01.010. Epub 2023 Feb 1. Mol Immunol. 2023. PMID: 36736195

2

Structure-based rational design of a novel chimeric PD1-NKG2D receptor for natural killer cells.

Guo C, Wang X, Zhang H, Zhi L, Lv T, Li M, Lu C, Zhu W. Guo C, et al. Mol Immunol. 2019 Oct;114:108-113. doi: 10.1016/j.molimm.2019.07.009. Epub 2019 Jul 24. Mol Immunol. 2019. PMID: 31351411

3

Aliiroseovarius marinus sp. nov., isolated from seawater.

Wang Y, Zhang Y, Guo C, Liu T, Dai Y, Lin M, Cui C, Zhang Y, Zhou C, Zhu W. Wang Y, et al. Among authors: guo c. Int J Syst Evol Microbiol. 2020 Jan;70(1):334-339. doi: 10.1099/ijsem.0.003757. Int J Syst Evol Microbiol. 2020. PMID: 31622234

4

A novel bispecific chimeric PD1-DAP10/NKG2D receptor augments NK92-cell therapy efficacy for human gastric cancer SGC-7901 cell.

Li M, Zhi L, Yin M, Guo C, Zhang H, Lu C, Zhu W. Li M, et al. Among authors: guo c. Biochem Biophys Res Commun. 2020 Mar 12;523(3):745-752. doi: 10.1016/j.bbrc.2020.01.005. Epub 2020 Jan 14. Biochem Biophys Res Commun. 2020. PMID: 31952789

5

VEGF165b and its mutant demonstrate immunomodulatory, not merely anti-angiogenic functions, in tumor-bearing mice.

Zhang H, Xia W, Liang C, Wang X, Zhi L, Guo C, Niu Z, Zhu W. Zhang H, et al. Among authors: guo c. Mol Immunol. 2020 Apr 27;122:132-140. doi: 10.1016/j.molimm.2020.04.005. Online ahead of print. Mol Immunol. 2020. PMID: 32353584

6

A novel chimeric PD1-NKG2D-41BB receptor enhances antitumor activity of NK92 cells against human lung cancer H1299 cells by triggering pyroptosis.

Lu C, Guo C, Chen H, Zhang H, Zhi L, Lv T, Li M, Niu Z, Lu P, Zhu W. Lu C, et al. Among authors: guo c. Mol Immunol. 2020 May 6;122:200-206. doi: 10.1016/j.molimm.2020.04.016. Online ahead of print. Mol Immunol. 2020. PMID: 32388482

7

VEGF165b augments NK92 cytolytic activity against human K562 leukemia cells by upregulating the levels of perforin and granzyme B via the VEGR1-PLC pathway.

Wang X, Liang C, Xia W, Guo C, Niu Z, Zhu W, Zhang H. Wang X, et al. Among authors: guo c. Mol Immunol. 2020 Dec;128:41-46. doi: 10.1016/j.molimm.2020.09.004. Epub 2020 Oct 14. Mol Immunol. 2020. PMID: 33068832

8

Chimeric antigen receptor-modified macrophages trigger systemic anti-tumour immunity.

Niu Z, Chen G, Chang W, Sun P, Luo Z, Zhang H, Zhi L, Guo C, Chen H, Yin M, Zhu W. Niu Z, et al. Among authors: guo c. J Pathol. 2021 Mar;253(3):247-257. doi: 10.1002/path.5585. Epub 2020 Dec 4. J Pathol. 2021. PMID: 33140856

9

Genetical engineering for NK and T cell immunotherapy with CRISPR/Cas9 technology: Implications and challenges.

Zhi L, Su X, Yin M, Zhang Z, Lu H, Niu Z, Guo C, Zhu W, Zhang X. Zhi L, et al. Among authors: guo c. Cell Immunol. 2021 Nov;369:104436. doi: 10.1016/j.cellimm.2021.104436. Epub 2021 Sep 1. Cell Immunol. 2021. PMID: 34500148 Review.

10

A chimeric switch-receptor PD1-DAP10-41BB augments NK92-cell activation and killing for human lung Cancer H1299 Cell.

Zhi L, Yin M, Su X, Zhang Z, Lu H, Li M, Guo C, Niu Z, Zhang X, Zhu W. Zhi L, et al. Among authors: guo c. Biochem Biophys Res Commun. 2022 Apr 16;600:94-100. doi: 10.1016/j.bbrc.2022.02.052. Epub 2022 Feb 16. Biochem Biophys Res Commun. 2022. PMID: 35217362

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,161 results

Search Page

Filters